Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Day One Biopharmaceuticals (DAWN) Operating Leases: 2022-2024

Historic Operating Leases for Day One Biopharmaceuticals (DAWN) over the last 2 years, with Dec 2024 value amounting to $2.6 million.

  • Day One Biopharmaceuticals' Operating Leases rose 7.64% to $2.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $2.7 million, marking a year-over-year increase of 7.64%. This contributed to the annual value of $2.6 million for FY2024, which is N/A change from last year.
  • According to the latest figures from FY2024, Day One Biopharmaceuticals' Operating Leases is $2.6 million, which was up 535.29% from $408,000 recorded in FY2022.
  • Day One Biopharmaceuticals' Operating Leases' 5-year high stood at $2.6 million during FY2024, with a 5-year trough of $408,000 in FY2022.
  • In the last 2 years, Day One Biopharmaceuticals' Operating Leases had a median value of $1.5 million in 2022 and averaged $1.5 million.